6D5B7F245W
(7R)-16-chloro-15-(2-fluoro-6-hydroxyphenyl)-7,9-dimethyl-12-(4-methyl-2-propan-2-yl-3-pyridinyl)-5-prop-2-enoyl-2,5,9,12,14-pentazatetracyclo[8.8.0.02,7.013,18]octadeca-1(10),13,15,17-tetraene-8,11-dione
Molecular Identity
6D5B7F245W
(7R)-16-chloro-15-(2-fluoro-6-hydroxyphenyl)-7,9-dimethyl-12-(4-methyl-2-propan-2-yl-3-pyridinyl)-5-prop-2-enoyl-2,5,9,12,14-pentazatetracyclo[8.8.0.02,7.013,18]octadeca-1(10),13,15,17-tetraene-8,11-dione
PubChem CID: 167713279
2D Structure
Properties
C33H32ClFN6O4
Molecular Formula
631.10
Molecular Weight
g/mol
630.2158
Exact Mass
Da
4.1
XLogP
Drug-like (Lipinski: < 5)
110
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
8
H-Bond Acceptors
1270
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(11)
6D5B7F245WRefChem:10855742641747-54-6Fulzerasibfulzerasib [INN]Fulzerasib [WHO-DD]EX-A8314A(4aR,8M)-11-chloro-10-(2-fluoro-6-hydroxyphenyl)-6- methyl-8-[2-(propan-2-yl)-4-methylpyridin-3-yl]-3-prop- 2-enoyl-2,3,4,4a,6,8-hexahydro-1H- pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7- dione(4aR,8M)-11-chloro-10-(2-fluoro-6-hydroxyphenyl)-6-methyl-8-[2-(propan-2-yl)-4-methylpyridin-3-yl]-3-prop-2-enoyl-2,3,4,4a,6,8-hexahydro-1H-pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione(4aR,8R)-11-Chloro-10-(2-fluoro-6-hydroxyphenyl)-2,3,4,4a,6,8-hexahydro-6-methyl-8-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-3-(1-oxo-2-propen-1-yl)-1H-pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione1H-Pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione, 11-chloro-10-(2-fluoro-6-hydroxyphenyl)-2,3,4,4a,6,8-hexahydro-6-methyl-8-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-3-(1-oxo-2-propen-1-yl)-, (4aR,8R)-
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to 6D5B7F245W
Loading drug network...